The findings, published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, offer new insight into how delusional beliefs may emerge and persist. Delusions are among the most recognizable symptoms of psychotic disorders: they are strongly held beliefs that remain resistant to contradictory evidence and can produce profound distress, social withdrawal, disability, and danger. Yet the cognitive processes that transform ordinary uncertainty into false certainty remain poorly understood. The new research points to the way people estimate environmental instability as one possible piece of that puzzle.

In computational psychiatry, a volatility prior describes a person’s expectation that the rules governing the world are likely to change. Someone with a relatively low volatility prior may assume that a pattern will remain stable unless there is strong evidence to the contrary. Someone with a high volatility prior, by contrast, may anticipate sudden shifts and treat the environment as unreliable, chaotic, or difficult to predict. Such expectations can influence how rapidly the brain updates its beliefs when new information arrives. When a person expects constant change, ambiguous events may be given disproportionate weight, potentially encouraging interpretations that become increasingly detached from external evidence.

Julia M. Sheffield, PhD, of Vanderbilt University Medical Center’s Department of Psychiatry and Behavioral Sciences, led the investigation to determine whether elevated volatility priors are a temporary feature of acute psychosis or a stable characteristic of people vulnerable to delusions. The distinction is clinically important. If volatility priors remain consistently high regardless of symptoms, they could represent a trait-like risk factor and a possible target for prevention. If they change alongside psychotic symptoms, they may instead function as a state marker—an indicator of the patient’s current clinical condition that could be influenced through treatment and recovery.

The research team recruited 75 adults with schizophrenia-spectrum disorders who had recently experienced an acute psychotic episode involving delusional thought content. Participants were assessed at six timepoints across six months, allowing investigators to track changes in cognition and symptoms rather than relying on a single snapshot. Their results were compared with data from 71 people without a diagnosed psychiatric disorder. To estimate volatility priors, participants completed a probabilistic reversal learning task, a behavioral experiment designed to measure how people respond when the relationship between choices and outcomes changes.

In this task, participants learn that one choice is more likely to produce a reward than another, but the probabilities periodically reverse. Successful performance requires tracking the environment, detecting when a pattern has changed, and adjusting behavior accordingly. The researchers used computational modeling to separate different components of decision-making, including how strongly participants expected the environment to shift. This approach does not directly measure a belief such as “the world is dangerous” or “people are plotting against me.” Instead, it estimates a more basic parameter governing belief updating: how much unpredictability a person expects before new evidence is presented.

At the beginning of the study, participants with schizophrenia-spectrum disorders showed significantly higher volatility priors than the non-clinical comparison group. Their delusional thinking, paranoia, and volatility expectations remained elevated at the end of the six-month follow-up and did not fully return to control levels. Nevertheless, all three measures generally declined over time, and the longitudinal analyses revealed that reductions in volatility priors were associated with improvements in delusion severity and paranoia. The relationship was specific: volatility priors were not significantly linked to changes in depression or worry, suggesting that the computational signal may be more closely related to psychotic belief formation than to general emotional distress.

The association remained after researchers accounted for antipsychotic medication and baseline cognitive ability. That finding does not show that changes in volatility priors caused delusions to improve, nor does it establish that modifying these expectations would necessarily eliminate psychotic symptoms. However, it strengthens the case that volatility priors track an important dimension of psychosis beyond medication exposure or overall intellectual performance. The researchers also found some evidence that the relationship was stronger for paranoid or persecutory delusions, in which people believe they are being watched, targeted, threatened, or harmed by others. Such beliefs may be particularly sensitive to expectations that social environments are unstable and unpredictable.

Repeated testing introduced an important complication. Participants completed the same type of task six times, and practice can alter performance independently of any genuine change in cognition. People may become faster, more accurate, or more familiar with the structure of an experiment simply because they have seen it before. The investigators attempted to reduce and account for these practice effects, but they acknowledge that the study remains partly confounded by repeated exposure. At the same time, the continued elevation of volatility priors after six months and six task sessions provided some reassurance that participants were not merely over-learning the experiment. The modeling results appeared to retain sensitivity to individual differences in volatility expectations beyond simple task familiarity.

The study’s implications extend beyond measurement. Antipsychotic medications, which broadly influence dopamine signaling, remain a central treatment for psychotic disorders, but responses vary substantially and many patients continue to experience delusions. Cognitive behavioral therapy for psychosis and other psychological interventions might eventually use computational information about belief updating to help patients examine how they interpret uncertainty and how rapidly they revise conclusions. A future treatment could, in principle, focus on recalibrating expectations about instability, helping individuals distinguish genuine changes in their environment from ordinary fluctuations or ambiguous events. Such an approach would need to be tested rigorously in controlled clinical trials before it could be considered an established therapy.

Sheffield and colleagues describe their results as foundational evidence that volatility priors are elevated during psychosis, decline during recovery, and move in parallel with the severity of specific delusional experiences. The work does not suggest that people with schizophrenia-spectrum disorders simply misread reality because they expect everything to change, nor does it reduce delusions to a single computational mechanism. Psychosis is biologically and psychologically diverse, and several interacting processes—including dopamine function, attention, learning, memory, social reasoning, and prior experiences—are likely to shape symptoms. Even so, identifying a measurable process that changes with recovery could help researchers connect laboratory models of belief updating with clinical treatment. The ultimate goal is to translate that connection into more precise and effective ways to reduce the disabling burden of delusions for patients and their families.

Subject of Research: People

Article Title: Longitudinal Associations Between Volatility Priors and Delusions in Individuals Recovering from an Acute Psychotic Episode

News Publication Date: August 18, 2026

Web References: https://doi.org/10.1016/j.bpsc.2026.06.013; Biological Psychiatry: Cognitive Neuroscience and Neuroimaging: https://www.sobp.org/bpcnni

References: Sheffield JM et al., “Longitudinal Associations Between Volatility Priors and Delusions in Individuals Recovering from an Acute Psychotic Episode,” Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, published July 3, 2026. DOI: 10.1016/j.bpsc.2026.06.013

Keywords: schizophrenia-spectrum disorders, delusions, psychosis, paranoia, volatility priors, computational psychiatry, belief updating, probabilistic reversal learning, cognitive markers, psychiatric treatment

Schizophrenia, long characterized by fragmented thought processes and altered reality perception, is a complex psychiatric condition that continues to challenge neuroscience due to its multifaceted nature. The orbitofrontal cortex, a brain region responsible for decision making, emotional regulation, and reward processing, emerges as a critical hub implicated in the disorder. The study by Zhang and colleagues leverages advanced neurostimulation techniques to not only modulate this area but also monitor consequent alterations in brain activity using EEG microstate analysis, a method that provides high temporal resolution insights into brain network dynamics.

EEG microstates are brief segments of quasi-stable scalp potential topographies, lasting roughly 60-120 milliseconds, reflecting the global activity of large-scale neural networks. These microstates provide a window into the temporal sequencing of cognitive processes and are increasingly recognized as electrophysiological signatures of mental states and psychiatric conditions. In schizophrenia, microstate abnormalities—such as altered duration or occurrence rates—have been consistently reported, correlating with symptoms like hallucinations and cognitive disruptions.

The authors adopted a protocol involving precise electrical stimulation of the OFC, designed to induce neuroplastic changes without causing adverse effects. By applying this stimulation, they aimed to assess both the immediate neural responses and the longer-term reorganization of brain activity patterns. The participants underwent multiple EEG sessions before, immediately after, and up to weeks following stimulation, allowing for a comprehensive temporal analysis of microstate dynamics.

One of the pivotal findings was the normalization of previously disrupted microstate parameters observed in schizophrenia. Immediately following OFC stimulation, there was a significant modulation toward microstate configurations resembling those typically seen in healthy controls, suggesting rapid neural recalibration. This implies that the OFC exerts a top-down influence on wide-ranging brain networks whose activities are reflected in microstate patterns, and that targeted stimulation can harness this effect to reset dysfunctional dynamics.

Moreover, the long-term follow-up data revealed sustained improvements in microstate stability and transition probabilities, hinting at durable neuroplastic adaptations induced by repeated OFC stimulation sessions. Such chronic shifts in brain network behaviors could be responsible for ameliorating symptom severity over time, marking a fundamental advance toward effective neuromodulatory treatments in schizophrenia.

From a mechanistic perspective, the stimulation likely modulates synaptic efficacy and functional connectivity between the OFC and other critical regions, including the dorsolateral prefrontal cortex, anterior cingulate cortex, and temporal lobes. These networks collectively contribute to cognitive control, social cognition, and sensory integration, domains notably impaired in schizophrenia. The microstate analysis provides an elegant, non-invasive biomarker to track these changes with unprecedented precision.

Importantly, the study navigated several technical challenges inherent in EEG microstate research. The researchers utilized sophisticated artifact correction methods and source localization algorithms to ensure the observed microstate transitions were neurogenic rather than noise-driven. Additionally, they incorporated rigorous statistical modeling to distinguish effects attributable to OFC stimulation from spontaneous fluctuations, bolstering the robustness of their conclusions.

This work also raises intriguing questions about the specificity and optimal parameters of brain stimulation in psychiatric conditions. The professionals tailored stimulation intensity and frequency to individual patient profiles, reflecting a move toward personalized neurotherapeutics. Such tailored approaches may help circumvent the heterogeneity that has traditionally hindered schizophrenia treatment advances.

Another noteworthy aspect is the synergistic use of electrophysiological and clinical assessments. Behavioral and symptomatic evaluations aligned with microstate changes, reinforcing the clinical relevance of the neurophysiological markers. This multimodal strategy enhances confidence that the observed EEG modifications are not merely electrophysiological curiosities but reflect meaningful brain-behavior relationships.

Beyond schizophrenia, these findings have broader implications for understanding the plastic capacity of the adult human brain. They affirm that focal modulation of key cortical hubs can ripple across distributed networks, reconfiguring fundamental brain activity patterns. This has potential utility in other neuropsychiatric disorders characterized by disrupted network dynamics, such as depression, bipolar disorder, and autism spectrum conditions.

The implications for future research are substantial. The study advocates for expanded clinical trials incorporating OFC stimulation protocols combined with longitudinal EEG microstate monitoring. Integrating neuroimaging modalities such as functional MRI could further elucidate structural-functional correlates of stimulation effects. Moreover, delineating the molecular underpinnings of observed network changes may pave the way for combined pharmacological and neuromodulatory interventions.

In conclusion, Zhang et al.’s pioneering investigation brings us closer to deciphering the elusive neurophysiological underpinnings of schizophrenia and forging novel paths for therapeutic intervention. Their demonstration that orbitofrontal cortex stimulation can recalibrate aberrant brain microstates opens an exciting frontier in safe, targeted treatment development that could profoundly improve patient outcomes. By marrying cutting-edge neurotechnology with detailed brain activity analysis, this study sets a new benchmark in psychiatric neuroscience, inspiring hope for millions impacted by schizophrenia worldwide.

Subject of Research: Immediate and long-term effects of orbitofrontal cortex stimulation on EEG microstates in schizophrenia

Article Title: Immediate and long-term effects of orbitofrontal cortex stimulation on EEG microstates in schizophrenia

Article References:
Zhang, K., Hu, Q., Zhang, Y. et al. Immediate and long-term effects of orbitofrontal cortex stimulation on EEG microstates in schizophrenia. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-03810-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-03810-3